Precision Business Insights has published a report on the global anti-infective market, estimating its value at USD 92,800 million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 1.4% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/anti-infective-market

The anti-infective market includes pharmaceuticals used to prevent, treat, or manage infections caused by bacteria, viruses, fungi, and parasites. These include antibiotics, antivirals, antifungals, and antiparasitic, all of which target infections. Anti-infectives are essential in both acute and chronic care settings, from normal outpatient therapy to intense hospital-based regimens.

Drivers:

• Rising Prevalence of Infectious Diseases
• Growing Healthcare Access in Emerging Markets

The global anti-infective market segmentation:

1) By Drug Type: Antibiotics, Antivirals, Antifungal, Others

2) By Disease condition: Respiratory Infection, Pneumonia, HIV, Tuberculosis, Others

3) By Route of Administration: Oral, Topical, Parentals and Others

4) By Distribution channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=63260

Regional Overview:
The report also examines the current concerns and their Future Effects on the anti-infective market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the anti-infective market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Pfizer Inc., Merck & Co., Inc., Gilead Sciences, Inc., AbbVie, Bristol-Myers Squibb, AstraZeneca, Sandoz International GmbH, Bayer AG, Xellia Pharmaceuticals, Mankind Pharma, B. Braun SE, Boehringer Ingelheim

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747